Outcomes of Elective Endovascular Aneurysmal Repair for Abdominal Aortic Aneurysms in Jordan
10.5758/vsi.2019.35.4.202
- Author:
Kristi E JANHO
1
;
Mohammed A RASHAIDEH
;
Jan SHISHANI
;
Muhannad JALOKH
;
Hazem HABOUB
Author Information
1. Vascular Surgery Department, King Hussin Medical Center at Royal Medical Services, Amman, Jordan. christiejanho2001@yahoo.com
- Publication Type:Original Article
- Keywords:
Endovascular;
Stent graft;
Abdominal aortic aneurysm;
Endoleak
- MeSH:
Aneurysm;
Aortic Aneurysm, Abdominal;
Blood Vessel Prosthesis;
Endoleak;
Extremities;
Femoral Artery;
Follow-Up Studies;
Groin;
Hematoma;
Humans;
Jordan;
Medical Records;
Middle East;
Mortality;
Retrospective Studies;
Seroma;
Transplants;
Wound Infection
- From:Vascular Specialist International
2019;35(4):202-208
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The outcomes of endovascular aneurysmal repair (EVAR) for infrarenal abdominal aortic aneurysms (AAAs) in the Middle East have rarely been reported. We analyzed the outcomes of EVAR in a Jordanian population.MATERIALS AND METHODS: We conducted a retrospective review of the medical records of patients with infrarenal AAA who were treated with elective EVAR between January 2004 and January 2017 at a single center in Jordan. Patient characteristics, anatomical characteristics, procedural details, and early and late postoperative outcomes were analyzed.RESULTS: A total of 288 patients (mean age, 70 years; 77.8% males) underwent EVAR for infrarenal AAA (median aneurysm size, 64 mm). Bifurcated endografts were used in 265 patients, and aorto-uni-iliac devices were used in 22 patients. Successful endograft deployment was achieved in all patients with no open conversion. Early complications included localized groin hematoma in 15, femoral artery dissection in 4, wound infection in 3, and seroma in 3 patients. With a mean follow-up of 60 months, 50 endoleaks were detected, including 9 type I, 38 type II, and 3 type III. Seven patients had unilateral graft limb occlusion. The 30-day mortality was 1.7%, and long-term mortality was 7.0%, mostly due to non-AAA-related causes.CONCLUSION: EVAR was safely performed in Jordanian patients with minimal complications. However, long-term surveillance is important due to the risk of endoleaks and consequent intervention.
